AI
White House Ousts AI Safety Researcher After Four Days, Accelerating Deregulation Push
Collin Burns' removal from federal AI role marks ideological purge of Biden-era safety advocates as EU and China lock in binding frameworks.
Google Taps Marvell for Custom AI Chips in Strategic Pivot from Broadcom Monopoly
The deal positions Marvell alongside Broadcom in the hyperscaler silicon market as cloud giants accelerate vertical integration to reduce NVIDIA dependency and optimize inference economics.
JPMorgan’s $9 Billion AI Bet Exposes Enterprise Adoption Friction
Bank's expense guidance triggered 4.7% stock decline, revealing gap between infrastructure euphoria and institutional execution reality.
Google commits $40 billion to Anthropic in largest AI investment on record
Tiered deal structure—$10B now, $30B conditional—pairs equity with guaranteed 5-gigawatt compute allocation, dwarfing Microsoft-OpenAI and signaling strategic pivot from horizontal LLM competition to infrastructure control.
Intel Posts Biggest Rally Since 1987 as AI Demand Rewrites Chipmaker Hierarchy
A 24% single-day surge driven by earnings beat and foundry wins signals market repricing of legacy players' AI competitiveness—but execution risk remains.
Oracle’s $16 Billion Michigan Data Center Financing Signals Tightening Credit Conditions for AI Infrastructure
PIMCO-backed deal closes after months of delays, revealing institutional skepticism even as hyperscalers commit $690 billion to AI capex in 2026.
DeepSeek’s V4 runs entirely on Chinese chips, challenging US export control strategy
New frontier model demonstrates that semiconductor restrictions may have accelerated architectural innovation rather than slowing China's AI development.
Google’s $40 Billion Anthropic Bet Rewrites AI Investment Playbook
Alphabet's performance-linked commitment to Claude's creator signals the end of monolithic AI development and the rise of strategic hedging across frontier labs.
Isomorphic Labs Enters Human Trials With AI-Designed Drugs, Testing Industry’s $3 Billion Bet
DeepMind spinoff's 2026 clinical trials mark first major test of whether machine learning can genuinely reduce drug failure rates beyond early-stage screening.
Anthropic’s Mythos AI Triggers Emergency Financial Regulatory Review as Autonomous Cybersecurity Crosses Threshold
Treasury and Federal Reserve convene emergency banking summit as new AI system autonomously exploits zero-day vulnerabilities faster than patches can deploy—testing whether existing governance frameworks can contain agent-level capabilities.
DeepSeek’s $6M Training Cost Threatens $650B AI Infrastructure Thesis
Chinese lab's efficiency breakthrough and Huawei chip debut force urgent reassessment of whether hyperscaler capex ROI assumptions survive the post-scale paradigm.
Meta’s 8,000 Job Cuts Expose the AI Profitability Crisis
As Meta slashes 10% of its workforce while committing $115B to AI infrastructure, the entire sector confronts a harsh truth: no one has figured out how to make money at this scale.